表紙
市場調査レポート

肺動脈高血圧症:世界の治験レビュー

Pulmonary Arterial Hypertension Global Clinical Trials Review, H2, 2013

発行 GlobalData 商品コード 222291
出版日 ページ情報 英文 213 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.51円で換算しております。
Back to Top
肺動脈高血圧症:世界の治験レビュー Pulmonary Arterial Hypertension Global Clinical Trials Review, H2, 2013
出版日: 2013年10月31日 ページ情報: 英文 213 Pages
概要

当レポートでは、世界各国における肺動脈高血圧症の臨床試験について調査し、地域・進捗状況・フェーズ(相)・募集状況別の実施件数や、代表的なスポンサー、開発中の治療薬の情報、各企業・機関での進行状況といった情報を盛り込んで、概略以下の構成でお届けします。

目次

  • イントロダクション
    • 肺動脈高血圧症
    • レポートガイダンス
  • 臨床試験 地域別
  • 臨床試験 国別
    • 臨床試験に寄与している上位5ヵ国 − アジア太平洋地域
    • 臨床試験に寄与している上位5ヵ国 − 欧州
    • 臨床試験に寄与している上位国 − 北米
    • 臨床試験に寄与している上位5ヵ国 − 中東およびアフリカ
    • 臨床試験に寄与している上位5ヵ国 − 中南米
  • 臨床試験 − BRIC 諸国
  • 臨床試験 − G7 諸国
  • 臨床試験 − G7 諸国 治験ステータス別
  • 臨床試験 − E7 諸国
  • 臨床試験 − E7 諸国 治験ステータス別
  • 臨床試験 相別
    • 進行中の治験 相別
  • 臨床試験 治験ステータス別
  • 未完了の治験
  • 期間ごとの被験者数
  • 有力なスポンサー
    • 主要な治験参加企業
  • 有望な治療薬比較
  • 臨床試験プロファイル
    • 臨床試験概要:上位企業
      • Actelion Ltd
      • Pfizer Inc.
      • United Therapeutics Corporation
      • Bayer AG
      • Gilead Sciences, Inc.
      • Novartis AG
      • GlaxoSmithKline plc
      • Lung Rx, Inc.
      • Eli Lilly and Company
      • EPIX Pharmaceuticals, Inc. (休止中)
      • Klinikum Wels - Grieskirchen GmbH
      • Aurora Health Care, Inc.
      • ICOS Corporation
      • Global Health Ventures Inc.
      • Berlin Chemi AG
      • Medtronic Cardiac Rhythm Disease Management
      • Arena Pharmaceuticals, Inc.
      • Aires Pharmaceuticals, Inc.
      • Boehringer Ingelheim GmbH
    • 臨床試験概要:トップレベルの大学 / 研究機関 / 病院
      • 慶應義塾大学
      • University of California, Los Angeles
      • Rabin Medical Center
      • Assistance Publique - Hopitaux de Paris
      • The Cleveland Clinic
      • University of Heidelberg
      • North Shore Long Island Jewish Health System
      • Medical University of Vienna
      • University of Cincinnati
      • Imperial College London
      • The University of Chicago
      • Zhejiang University
      • Mayo Clinic
      • Cardiovascular Institute & Fuwai Hospital
      • University of North Carolina Project
      • Odense University Hospital
      • Nantes University Hospital
      • Radboud University
      • University of Alabama at Birmingham
      • UMC Utrecht
  • 5大主要臨床プロファイル

付録

図表一覧


このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDHC1799CTIDB

GlobalData's clinical trial report, "Pulmonary Arterial Hypertension Global Clinical Trials Review, H2, 2013" provides data on the Pulmonary Arterial Hypertension clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Pulmonary Arterial Hypertension. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Pulmonary Arterial Hypertension. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Pulmonary Arterial Hypertension
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by BRIC Nations
  • Clinical Trials by G7 Nations
  • Clinical Trials in G7 Nations by Trial Status
  • Clinical Trials by E7 Nations
  • Clinical Trials in E7 Nations by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Unaccomplished Trials of Pulmonary Arterial Hypertension
  • Subjects Recruited Over a Period of Time
  • Prominent Sponsors
    • Top Companies Participating in Pulmonary Arterial Hypertension Therapeutics Clinical Trials
  • Prominent Drug Comparison
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Actelion Ltd
      • Clinical Trial Overview of Actelion Ltd
      • United Therapeutics Corporation
      • Clinical Trial Overview of United Therapeutics Corporation
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • Gilead Sciences, Inc.
      • Clinical Trial Overview of Gilead Sciences, Inc.
      • Bayer AG
      • Clinical Trial Overview of Bayer AG
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • GlaxoSmithKline plc
      • Clinical Trial Overview of GlaxoSmithKline plc
      • Lung Rx, LLC
      • Clinical Trial Overview of Lung Rx, LLC
      • Eli Lilly and Company
      • Clinical Trial Overview of Eli Lilly and Company
      • Aires Pharmaceuticals, Inc.
      • Clinical Trial Overview of Aires Pharmaceuticals, Inc.
    • Clinical Trial Overview of Top Institutes / Government
      • Keio University
      • Clinical Trial Overview of Keio University
      • The Cleveland Clinic
      • Clinical Trial Overview of The Cleveland Clinic
      • Assistance Publique - Hopitaux de Paris
      • Clinical Trial Overview of Assistance Publique - Hopitaux de Paris
      • Rabin Medical Center
      • Clinical Trial Overview of Rabin Medical Center
      • University of California, Los Angeles
      • Clinical Trial Overview of University of California, Los Angeles
      • National Heart, Lung, and Blood Institute
      • Clinical Trial Overview of National Heart, Lung, and Blood Institute
      • Imperial College London
      • Clinical Trial Overview of Imperial College London
      • VU University Medical Center
      • Clinical Trial Overview of VU University Medical Center
      • National Institutes of Health Clinical Center
      • Clinical Trial Overview of National Institutes of Health Clinical Center
      • University of Zurich
      • Clinical Trial Overview of University of Zurich
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Pulmonary Arterial Hypertension Therapeutics Market, Global, Clinical Trials by Zone, 2013*
  • Pulmonary Arterial Hypertension Therapeutics Market, Global, Clinical Trials by Top Countries, 2013*
  • Pulmonary Arterial Hypertension Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013*
  • Pulmonary Arterial Hypertension Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2013*
  • Pulmonary Arterial Hypertension Therapeutics Clinical Trials, Europe, Top Five Countries, 2013*
  • Pulmonary Arterial Hypertension Therapeutics Clinical Trials, North America, Top Countries, 2013*
  • Pulmonary Arterial Hypertension Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2013*
  • Pulmonary Arterial Hypertension Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2013*
  • Pulmonary Arterial Hypertension Therapeutics Clinical Trials, BRIC Countries, 2013*
  • Pulmonary Arterial Hypertension Therapeutics Clinical Trials, G7 Countries, 2013*
  • Pulmonary Arterial Hypertension Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013*
  • Pulmonary Arterial Hypertension Therapeutics Clinical Trials, E7 Countries, 2013*
  • Pulmonary Arterial Hypertension Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013*
  • Pulmonary Arterial Hypertension Therapeutics Market, Global, Clinical Trials by Phase, 2013*
  • Pulmonary Arterial Hypertension Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013*
  • Pulmonary Arterial Hypertension Therapeutics Market, Global, Clinical Trials by Trial Status, 2013*
  • Pulmonary Arterial Hypertension Therapeutics Market, Global, Suspended Clinical Trials, 2013*
  • Pulmonary Arterial Hypertension Therapeutics Market, Global, Withdrawn Clinical Trials, 2013*
  • Pulmonary Arterial Hypertension Therapeutics Market, Global, Terminated Clinical Trials, 2013*
  • Pulmonary Arterial Hypertension Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012
  • Pulmonary Arterial Hypertension Therapeutics Clinical Trials, Global, Key Sponsors, 2013*
  • Pulmonary Arterial Hypertension Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013*
  • Pulmonary Arterial Hypertension Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013*
  • Pulmonary Arterial Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Actelion Ltd, 2013*
  • Pulmonary Arterial Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by United Therapeutics Corporation, 2013*
  • Pulmonary Arterial Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2013*
  • Pulmonary Arterial Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Gilead Sciences, Inc., 2013*
  • Pulmonary Arterial Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2013*
  • Pulmonary Arterial Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2013*
  • Pulmonary Arterial Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2013*
  • Pulmonary Arterial Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Lung Rx, LLC, 2013*
  • Pulmonary Arterial Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2013*
  • Pulmonary Arterial Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Aires Pharmaceuticals, Inc., 2013*
  • Pulmonary Arterial Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Keio University, 2013*
  • Pulmonary Arterial Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by The Cleveland Clinic, 2013*
  • Pulmonary Arterial Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2013*
  • Pulmonary Arterial Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Rabin Medical Center, 2013*
  • Pulmonary Arterial Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Los Angeles, 2013*
  • Pulmonary Arterial Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2013*
  • Pulmonary Arterial Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Imperial College London, 2013*
  • Pulmonary Arterial Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by VU University Medical Center, 2013*
  • Pulmonary Arterial Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institutes of Health Clinical Center, 2013*
  • Pulmonary Arterial Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Zurich, 2013*

List of Figures

  • Pulmonary Arterial Hypertension Therapeutics Market, Global, Clinical Trials by Zone (%), 2013*
  • Pulmonary Arterial Hypertension Therapeutics Market, Global, Clinical Trials by Top Countries, 2013*
  • Pulmonary Arterial Hypertension Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013*
  • Pulmonary Arterial Hypertension Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2013*
  • Pulmonary Arterial Hypertension Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013*
  • Pulmonary Arterial Hypertension Therapeutics Clinical Trials, North America, Top Countries (%), 2013*
  • Pulmonary Arterial Hypertension Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2013*
  • Pulmonary Arterial Hypertension Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2013*
  • Pulmonary Arterial Hypertension Therapeutics Clinical Trials, BRIC Countries (%), 2013*
  • Pulmonary Arterial Hypertension Therapeutics Clinical Trials, G7 Countries (%), 2013*
  • Pulmonary Arterial Hypertension Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013*
  • Pulmonary Arterial Hypertension Therapeutics Clinical Trials, E7 Countries (%), 2013*
  • Pulmonary Arterial Hypertension Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013*
  • Pulmonary Arterial Hypertension Therapeutics Market, Global, Clinical Trials by Phase (%), 2013*
  • Pulmonary Arterial Hypertension Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013*
  • Pulmonary Arterial Hypertension Therapeutics Market, Global, Clinical Trials by Trial Status, 2013*
  • Pulmonary Arterial Hypertension Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012
  • Pulmonary Arterial Hypertension Therapeutics Clinical Trials, Global, Key Sponsors, 2013*
  • Pulmonary Arterial Hypertension Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013*
  • Pulmonary Arterial Hypertension Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013*
  • GlobalData Methodology
Back to Top